4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-329804
EVP, Chief Development Officer gave up 6,674 shares (to pay taxes)
- EVP, Chief Development Officer acquired 23,463 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · EVP, Chief Development Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-30 | Exercise or conversion : show line 1 in the form | +11,769 | 236,153 | D | ||
| 2026-07-30 | Shares withheld for taxes : show line 2 in the form | −3,348 | $0.50 | $1,674 | 232,805 | D |
| 2026-07-31 | Exercise or conversion : show line 3 in the form | +11,694 | 244,499 | D | ||
| 2026-07-31 | Shares withheld for taxes : show line 4 in the form | −3,326 | $0.50 | $1,663 | 241,173 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-30 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −11,769 | 164,776 | D |
| 2026-07-31 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −11,694 | 116,944 | D |
Loading xslF345X06/ownership.xml…